sgrosche.bsky.social
@sgrosche.bsky.social
Reposted
The @fda.gov granted accelerated approval to the HER2 inhibitor zongertinib for certain adults with unresectable or metastatic non-squamous non-small cell lung cancer whose tumors harbored mutations in the tyrosine kinase domain of HER2: buff.ly/Fq0u3yt
FDA grants accelerated approval to zongertinib for non-squamous NSCLC
On August 8, 2025, the Food and Drug Administration granted accelerated approval to zongertinib (Hernexeos, Boehringer Ingelheim Pharmaceuticals, Inc.), a kinas
www.fda.gov
August 8, 2025 at 6:50 PM
Reposted
"There’s really only one advice: work as hard as you can. [...] If more of us are trying, more of us are succeeding, and others are being carried through", says @apombo1.bsky.social Pombo, group leader at the #mdcBerlin#mdcBIMSB.

👇 Watch the video and share to inspire others!
Celebrating our #WomenInSTEM: Ana Pombo
YouTube video by Max Delbrück Center
youtu.be
February 17, 2025 at 8:31 AM
Reposted
Are you a student with an interest in translational #cancer research? The lab of our Johannes Zuber (@johanneszuber.bsky.social) is recruiting a #masters student: www.imp.ac.at/career/open-...

#oncology, #cancerresearch, #masters
Ref2501: Master thesis in Translational Cancer Research (Zuber lab) | Research Institute of Molecular Pathology
www.imp.ac.at
January 7, 2025 at 4:28 PM